- Home
- MTSI vs JNJ Comparison
MTSI vs JNJ Comparison
Compare MTSI & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTSI | JNJ |
|---|---|---|
| Founded | 1950 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 589.2B |
| IPO Year | 2012 | 1944 |
Fundamental Metrics
Financial Performance| Metric | MTSI | JNJ |
|---|---|---|
| Price | $244.03 | $243.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 17 |
| Target Price | ★ $232.60 | $227.29 |
| AVG Volume (30 Days) | 1.5M | ★ 9.2M |
| Earning Date | 02-05-2026 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | ★ 71.26 |
| EPS | 2.17 | ★ 11.03 |
| Revenue | $1,020,748,000.00 | ★ $94,193,000,000.00 |
| Revenue This Year | $18.69 | $6.63 |
| Revenue Next Year | $13.24 | $7.21 |
| P/E Ratio | $110.27 | ★ $22.17 |
| Revenue Growth | ★ 29.12 | 5.08 |
| 52 Week Low | $84.00 | $141.50 |
| 52 Week High | $245.26 | $246.35 |
Technical Indicators
Market Signals| Indicator | MTSI | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 62.32 | 83.07 |
| Support Level | $225.98 | $237.40 |
| Resistance Level | $245.26 | $246.35 |
| Average True Range (ATR) | 13.13 | 3.66 |
| MACD | -0.43 | 0.87 |
| Stochastic Oscillator | 78.12 | 90.12 |
Price Performance
Historical ComparisonAbout MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.